Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Atherosclerosis

• Publication date

  2000-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0021-9150(99)00393-7PMID 10856525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lovastatin-Induced Proliferation Inhibition and Apoptosis in C 6 Glial Cells 1

  1999cited by this paper
• Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences

  1999cited by this paper
• Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.

  1999cited by this paper
• Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders.

  1999cited by this paper
• Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition.

  1999cited by this paper
• Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.

  1999cited by this paper
• Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus.

  1998cited by this paper
• Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells*

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.

  1997cited by this paper
• A simple method for the flow cytometric analysis of intracellular antigens in whole smooth muscle cells: quantification of cyclin-dependent kinase 2.

  1997cited by this paper
• Translational Control of p27Kip1 Accumulation During the Cell Cycle

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.

  1996cited by this paper
• Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.

  1996cited by this paper
• Biochemical properties and biological effects of p53.

  1995cited by this paper
• Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways.

  1995cited by this paper
• Multiple growth factors are released from mechanically injured vascular smooth muscle cells.

  1995cited by this paper
• Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition

  1995cited by this paper
• Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.

  1994cited by this paper
• Expression of wild-type p53 during the cell cycle in normal human mammary epithelial cells.

  1994cited by this paper
• Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993influential reference
• Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.

  1991cited by this paper
• Prevention of restenosis by lovastatin after successful coronary angioplasty.

  1991cited by this paper
• Cell cycle-specific effects of lovastatin.

  1991cited by this paper
• Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients.

  1991cited by this paper
• Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative.

  1988cited by this paper
• Amplification of the gene for 3-hydroxy-3-methylglutaryl coenzyme A reductase, but not for the 53-kDa protein, in UT-1 cells.

  1983cited by this paper
• Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1982cited by this paper
• Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

  1977influential reference

• Effect of statin treatment on preterm labour

  2017cites this paper
• Strategies to Extend the Life of Saphenous Vein Grafts

  2016cites this paper
• Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells

  2015cites this paper
• mTOR regulates Aurora A via enhancing protein stability

  2014cites this paper
• Influence of Degradable Polar Hydrophobic Ionic Polyurethanes and Cyclic Mechanical Strain on Vascular Smooth Muscle Cell Function and Phenotype

  2012cites this paper
• Targeted Treatments for Restenosis and Vein Graft Disease

  2012cites this paper
• Fluvastatin

  2012cites this paper
• Functional characterization of human coronary artery smooth muscle cells under cyclic mechanical strain in a degradable polyurethane scaffold.

  2011cites this paper
• Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?

  2011cites this paper
• Statins Promote the Growth of Experimentally Induced Cerebral Aneurysms in Estrogen-Deficient Rats

  2011cites this paper
• Statins inhibit iNOS‐mediated microbicidal potential of activated monocyte‐derived dendritic cells by an IFN‐β‐dependent mechanism

  2011cites this paper
• Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers.

  2010cites this paper
• Impact of immunosuppressive drugs on the development of cardiac allograft vasculopathy.

  2010cites this paper
• Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?

  2010cites this paper
• Effects of Statins on Progression of Carotid Atherosclerosis as Measured By Carotid Intimal—Medial Thickness: A Meta-Analysis of Randomized Controlled Trials

  2010cites this paper
• Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells From Patients With Idiopathic Pulmonary Arterial Hypertension

  2010influential citation
• Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells.

  2010cites this paper
• Thickness : A Meta-Analysis of Randomized Controlled Trials Medial − − Effects of Statins on Progression of Carotid Atherosclerosis as Measured By Carotid Intimal

  2010cites this paper
• Statin prescription by Croatian family doctors lack of systematic proactive approach to cardiovascular disease prevention.

  2009cites this paper
• Die Rolle des Tumorsuppressorproteins p53 bei der Apoptoseregulation glatter Gefäßmuskelzellen der Neointima

  2009cites this paper
• Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53.

  2008cites this paper
• Statins in prevention and therapy of cancer

  2008cites this paper
• Interactions between cell death induced by statins and 7‐ketocholesterol in rabbit aorta smooth muscle cells

  2008cites this paper
• Endothelial injury in cardiac transplantation : the role of endothelin antagonism and protein kinases.

  2008cites this paper
• SIMVASTATIN INCORPORATED PERIVASCULAR POLYMERIC CONTROLLED DRUG DELIVERY SYSTEM FOR THE INHIBITION OF VASCULAR WALL INTIMAL HYPERPLASIA

  2007cites this paper
• Bilirubin and Biliverdin Treatment of Atherosclerotic Diseases

  2007cites this paper
• Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection.

  2007cites this paper
• Charakterisierung der Effekte verschiedener differenzierungsaktiver Substanzen auf Apoptose, Proliferation, Iodidstoffwechsel, Pendrin- und NIS-Expression in der cancerogenen Schilddrüsenzelllinie CGTH-W-1

  2007cites this paper
• Red yeast rice stimulates bone formation in rats

  2006cites this paper
• Aus der Medizinischen Universitätsklinik Tübingen Abteilung Endokrinologie, Stoffwechsel und Pathobiochemie

  2006cites this paper
• The role of statins in cancer therapy.

  2006cites this paper
• The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

  2006cites this paper
• Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta

  2005cites this paper
• Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins.

  2005cites this paper
• HMG-CoA reductase inhibitors suppress the development and progression of carotid artery intimal-medial thickening in hypercholesterolemic type 2 diabetic patients.

  2005cites this paper
• Statins and Modulation of Oxidative Stress

  2005cites this paper
• Cardiac allograft vasculopathy: a review.

  2005cites this paper
• Cerivastatin-induced apoptosis of human aortic smooth muscle cells through partial inhibition of basal activation of extracellular signal-regulated kinases.

  2004cites this paper
• Biological aspects of radiation and drug-eluting stents for the prevention of restenosis.

  2004cites this paper
• Antiproliferative effects of immunosuppressant drugs on vascular smooth muscle cells: an additional advantage for attenuating transplant vasculopathy.

  2004cites this paper
• Acute Vasodilator Effects of HMG‐CoA Reductase Inhibitors: Involvement of P13‐kinase/Akt Pathway and Kv Channels

  2003cites this paper
• HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells.

  2003cites this paper
• Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors.

  2003cites this paper
• Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.

  2003cites this paper
• Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells.

  2003cites this paper
• Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway.

  2003cites this paper
• Vergleichende Untersuchung der Wirkung verschiedener HMG-CoA Reduktase Inhibitoren auf die Apoptose normaler und neointimaler Gefäßmuskelzellen

  2003influential citation
• Potential antitumor effects of statins (Review).

  2003cites this paper
• Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300252-JLR200

  2003cites this paper
• Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice

  2002cites this paper
• HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins

  2002influential citation
• Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice.

  2002cites this paper
• Impact of cellular pathways of fatty acid metabolism and cholesterol synthesis on cardiomyocyte cell death

  2002cites this paper
• Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C

  2002cites this paper
• Synergistic interaction of lovastatin and paclitaxel in human cancer cells.

  2001cites this paper
• Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate-independent pathways

  2001cites this paper
• Statins and bone formation.

  2001cites this paper